Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 10, 2016 - Issue 2
Submit an article Journal homepage
172
Views
1
CrossRef citations to date
0
Altmetric
Original research

Cardiovascular risk in pulmonary alveolar proteinosis

Effrosyni D. Manali2nd Pulmonary Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Georgia Papadaki2nd Pulmonary Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Dimitrios Konstantonis2nd Critical Care Department, Pulmonary Hypertension Clinic, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Iraklis Tsangaris2nd Critical Care Department, Pulmonary Hypertension Clinic, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Andriana I. Papaioannou2nd Pulmonary Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Likurgos Kolilekas7th Pulmonary Department and Asthma Center, Athens Chest Hospital, Athens, Greece
,
Andrea SchamsHauner Children’s University Hospital, Ludwig-Maximilians University, German Center for Lung Research, Munich, Germany
,
Konstantinos Kagouridis2nd Pulmonary Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Anna Karakatsani2nd Pulmonary Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Stylianos Orfanos2nd Critical Care Department, Pulmonary Hypertension Clinic, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Matthias GrieseHauner Children’s University Hospital, Ludwig-Maximilians University, German Center for Lung Research, Munich, Germany
&
Spyros A. Papiris2nd Pulmonary Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
 show all
Pages 235-240 | Received 08 Aug 2015, Accepted 02 Nov 2015, Published online: 27 Nov 2015

References

•  A review paper of interest about all forms of pulmonary alveolar proteinosis focusing on new evidence about the role of new treatments, mostly inhaled GM-CSF, in autoimmune pulmonary alveolar proteinosis

•• An excellent review describing the history and the progress concerning pulmonary alveolar proteinosis

  • Papaioannou AI, Bartziokas K, Loukides S, et al. Cardiovascular comorbidities in hospitalized COPD patients: a determinant of future risk? Eur Respir J. 2015;46(3):846–849.
  • Hubbard RB, Smith C, Le Jeune I, et al. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med. 2008;178:1257–1261.
  • Yoshida M, Ikegami M, Reed JA, et al. GMCSF regulates protein and lipid catabolism by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2001;280:L379–L386.
  • Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte macrophage colony stimulating factor. J Exp Med. 1999;190:875–880.

•• An excellent research paper demonstrating that idiopathic pulmonary alveolar proteinosis is an autoimmune disease related with neutralizing antibody against granulocyte macrophage colony stimulating factor leading to alveolar macrophage dysfunction

  • Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008;177:752–762.

• An important paper about the characteristics of 223 patients with autoimmune PAP in Japan as well as about the role of the disease severity score and biomarkers in the outcome of the disease

  • Bonella F, Bauer PC, Griese M, et al. Pulmonary alveolar proteinosis: new insights from a single center cohort of 70 patients. Respir Med. 2011;105(12):1908–1916.

• Important paper about the characteristics of 70 patients with PAP in Europe. Significant insights are provided about the role of environmental exposures and smoking as well as about the response of patients to treatment with whole lung lavage

  • Fang CS, Wang YC, Zhang TH, et al Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis. Lipids Health Dis. 2012;11:12.
  • Veldhuisen R, Nag K, Orgeig S, et al. The role of lipids in pulmonary surfactant. Biochem Biophys Acta. 1998;1408:90–108.
  • Meaney S, Bonfield TL, Hansson M, et al. Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis. J Lipid Res. 2004;45:2354–2360.
  • Tian X, Luo J, Xu KF, et al. Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis. Lipids Health Dis. 2011;10:54.
  • Perk J, De Backer G, Gohlke H, et al. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts): European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). European Heart Journal. 2012;33:1635–1701.
  • Seeger W, Adir Y, Barberà JA, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013;62(25 Suppl):D109–16.
  • Bhatt P, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res. 2013;162:237–251.
  • Cruz JA, Bauer EM, Rodriguez AI, et al. Chronic hypoxia induces right heart failure in caveolin-1 -/- mice. Am J Physiol Heart Circ Physiol. 2012;302:H2518–2527.
  • Latzin P, Tredano M, Wüst Y, et al. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Epidemiologic and clinical information. Thorax. 2005;60:39–44.

•• An excellent paper about the role of anti-GM-CSF antibodies in pediatric pulmonary alveolar proteinosis

  • Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2010 181:1345–1354.

•• Excellent research paper about inhaled GM-CSF as treatment for autoimmune pulmonary alveolar proteinosis.

  • Inoue Y, Nakata K, Arai T, et al. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Respirology. 2006;11(Suppl):S55–60.
  • Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. Jacc. 2013;62:d42–50.
  • Papiris SA, Tsirigotis P, Kolilekas L, et al. Long-term inhaled granulocyte macrophage-colony stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, lowest-effective dose. Clin Drug Invest. 2014;34(8):553–564.
  • Panagopoulou V, Deftereos S, Kossyvakis C, et al. NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem. 2013;13:82–94.
  • Søyseth V, Bhatnagar R, Holmedahl NH, et al. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T. Heart. 2013;99:122–126.
  • Hakemi EU, Alyousef T, Dang G, et al. The prognostic value of undetectable highly sensitive cardiac troponin I in patients with acute pulmonary embolism. Chest. 2015;147:685–694.
  • Pavasini R, d’Ascenzo F, Campo G, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis. Int J Cardiol. 2015;191:187–193.
  • Gale CP, White JE, Hunter A, et al. Predicting mortality and hospital admission in patients with COPD: significance of NT-pro BNP, clinical and echocardiographic assessment. J Cardiovasc Med (Hagerstown). 2011;12:613–618.
  • Ando T, Ogawa K, Yamaki K, et al. Plasma concentrations of atrial, brain and c-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases. Chest. 1996;110:462–468.
  • Hopkins WE, Chen Z, Fukagawa NK, et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease. Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation. 2004;109:2872–2877.
  • McDermott H, Aitchison F, Nathani N, et al. A case report of pulmonary alveolar proteinosis. BMJ Case Rep. 2009; 2009: pii: bcr04.2009.1796.
  • Moisan M, Lafargue M, Calderon J, et al. Pulmonary alveolar proteinosis requiring “hybrid” extracorporeal life support, and complicated by acute necrotizing pneumonia. Ann Fr Anesth Reanim. 2013;32:e71–e75.
  • Simonneau G, Gatzoulis MA, Adatia I, et al Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D 34–41.
  • Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010;135(2):223–235.

•• Excellent paper about how the loss of GM-CSF signaling blocks terminal differentiation of alveolar macrophages impairing processing of surfactant as well as many host defenses

  • Bonella F, Theegarten D, Guzman J, et al. Alveolar lipoproteinosis syndromes. Eur Respir Mon. 2011;54:171–186.

• An important review paper about lipoproteinosis syndromes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.